Alnylam Pharmace. buy AlexM84
Start price
17.03.24
/
50%
€134.80
Target price
17.04.24
-
Performance (%)
0.48%
End price
18.04.24
€135.45
Summary
This prediction ended on 18.04.24 with a price of €135.45. During the runtime of the prediction for Alnylam Pharmace. the price only changed by 0.48%. AlexM84 has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -14.786% | -14.786% | 43.367% |
| iShares Core DAX® | 1.803% | 0.496% | 18.553% |
| iShares Nasdaq 100 | 0.429% | -0.410% | 8.908% |
| iShares Nikkei 225® | 0.708% | -3.799% | 12.088% |
| iShares S&P 500 | 0.288% | -0.218% | 3.736% |
Comments by AlexM84 for this prediction
In the thread Trading Alnylam Pharmace.
Die von AlexM84 gewählte maximale Laufzeit wurde überschritten